Literature DB >> 21221577

Biochemical markers in the diagnosis of chondral defects following anterior cruciate ligament insufficiency.

Nikolaus A Streich1, David Zimmermann, Holger Schmitt, Gerrit Bode.   

Abstract

PURPOSE: The aim of this study was to determine the value of systemic biochemical markers of bone turnover-urine levels of cross-linked C-terminal telopeptide I (uCTX-I), urinary C-terminal telopeptide II (uCTX-II) and serum cartilage oligomeric matrix protein (sCOMP)-in the diagnosis of chondral defects after anterior cruciate ligament (ACL) rupture. Thirty-eight patients with previous ACL rupture were included.
METHODS: Magnetic resonance imaging (MRI) of the injured and the intact knee joint was performed with volumetric measurement of volume and area of cartilage (VC/AC), area of subchondral bone (cAB), and area of subchondral bone denuded and eroded (dAB). Biochemical markers were measured using commercially available enzyme-linked immunoassays.
RESULTS: MRI-based volumetric cartilage measurement showed significant differences between the injured and the intact knees. uCTX-I, sCOMP and in parts uCTX-II correlated well with MRI parameters. CTX-I showed a significant correlation with VC and AC of the whole knee joint.
CONCLUSIONS: The results suggest that uCTX-I, uCTX-II and sCOMP could identify patients with focal cartilage lesions from an early stage of osteoarthritis of the knee.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21221577      PMCID: PMC3193972          DOI: 10.1007/s00264-010-1191-5

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  23 in total

Review 1.  Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases.

Authors:  P Garnero; J C Rousseau; P D Delmas
Journal:  Arthritis Rheum       Date:  2000-05

2.  Is the progression of osteoarthritis phasic? Evidence and implications.

Authors:  J R Kirwan; C J Elson
Journal:  J Rheumatol       Date:  2000-04       Impact factor: 4.666

3.  Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers.

Authors:  E Vignon; P Garnero; P Delmas; B Avouac; P Bettica; M Boers; E Ehrich; N MacKillop; L Rovati; U Serni; T Spector; J Y Reginster
Journal:  Osteoarthritis Cartilage       Date:  2001-05       Impact factor: 6.576

4.  Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.

Authors:  P Garnero; M Piperno; E Gineyts; S Christgau; P D Delmas; E Vignon
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

5.  No loss of cartilage volume over three years in patients with knee osteoarthritis as assessed by magnetic resonance imaging.

Authors:  S J Gandy; P A Dieppe; M C Keen; R A Maciewicz; I Watt; J C Waterton
Journal:  Osteoarthritis Cartilage       Date:  2002-12       Impact factor: 6.576

6.  Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.

Authors:  O Bruyere; J Collette; M Kothari; S Zaim; D White; H Genant; C Peterfy; N Burlet; D Ethgen; T Montague; C Dabrowski; J-Y Reginster
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

7.  A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis--association with disease progression.

Authors:  M Sharif; J Kirwan; N Charni; L J Sandell; C Whittles; P Garnero
Journal:  Rheumatology (Oxford)       Date:  2007-03-26       Impact factor: 7.580

Review 8.  Osteoarthritis of the peripheral joints.

Authors:  Ingemar F Petersson; Lennart T H Jacobsson
Journal:  Best Pract Res Clin Rheumatol       Date:  2002-12       Impact factor: 4.098

9.  Collagen type II C-telopeptide fragments as an index of cartilage degradation.

Authors:  S Christgau; P Garnero; C Fledelius; C Moniz; M Ensig; E Gineyts; C Rosenquist; P Qvist
Journal:  Bone       Date:  2001-09       Impact factor: 4.398

10.  Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.

Authors:  Patrick Garnero; Robert Landewé; Maarten Boers; Arco Verhoeven; Sjef Van Der Linden; Stephan Christgau; Désirée Van Der Heijde; Annelies Boonen; Piet Geusens
Journal:  Arthritis Rheum       Date:  2002-11
View more
  1 in total

1.  Anterior cruciate ligament deficiency leads to early instability of scaffold for cartilage regeneration: a controlled laboratory ex-vivo study.

Authors:  Turgay Efe; Alexander Füglein; Alan Getgood; Thomas J Heyse; Susanne Fuchs-Winkelmann; Thilo Patzer; Bilal F El-Zayat; Stefan Lakemeier; Markus D Schofer
Journal:  Int Orthop       Date:  2011-12-06       Impact factor: 3.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.